World's Best Scientists 2026 revealed!
Wolf-Henning Boehncke

Wolf-Henning Boehncke

D-Index & Metrics

Biology and Biochemistry

D-Index
76
Citations
23195
World Ranking
5003
National Ranking
97

Wolf-Henning Boehncke publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Wolf-Henning Boehncke sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 377 publications — 88th percentile

88% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Wolf-Henning Boehncke D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Wolf-Henning Boehncke sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 76 D-Index — 75th percentile

75% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Wolf-Henning Boehncke is affiliated with the University of Geneva in Switzerland. Their academic output is primarily situated within the fields of Medicine and Immunology and Microbiology, with significant contributions to related subfields such as Immunology, Rheumatology, Dermatology, Hematology, and Pathology and Forensic Medicine.

The scientist's research topics encompass:

  • Psoriasis: Treatment and Pathogenesis
  • Spondyloarthritis Studies and Treatments
  • Dermatology and Skin Diseases
  • Rheumatoid Arthritis Research and Therapies
  • Autoimmune and Inflammatory Disorders Research
  • Health Systems, Economic Evaluations, Quality of Life
  • Pharmaceutical studies and practices

Frequent publication venues for Wolf-Henning Boehncke include:

  • Annals of the Rheumatic Diseases
  • JDDG Journal der Deutschen Dermatologischen Gesellschaft
  • Journal of the European Academy of Dermatology and Venereology
  • Journal of the American Academy of Dermatology
  • Revue Médicale Suisse

Collaborative work is an essential component of their research, with frequent coauthors including:

  • Nicolò Costantino Brembilla
  • Christopher T. Ritchlin
  • A. Kollmeier
  • Iain B. McInnes
  • Philip J. Mease

Some of the notable recent papers authored or coauthored by Wolf-Henning Boehncke are:

  • EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update, 2020, Annals of the Rheumatic Diseases
  • Guselkumab in patients with active psoriatic arthritis who were biologic-naive or had previously received TNFα inhibitor treatment (DISCOVER-1): a double-blind, randomised, placebo-controlled phase 3 trial, 2020, The Lancet
  • Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statement, 2020, Annals of the Rheumatic Diseases
  • EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update, 2024, Annals of the Rheumatic Diseases
  • IL-17A in Psoriasis and Beyond: Cardiovascular and Metabolic Implications, 2020, Frontiers in Immunology

Best Publications

  • Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 Treatment Recommendations for Psoriatic Arthritis

    Laura C. Coates;Arthur Kavanaugh;Philip J. Mease;Enrique R. Soriano

  • EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update

    Laure Gossec;Xenofon Baraliakos;Andreas Kerschbaumer;Maarten de Wit

  • Treatment recommendations for psoriatic arthritis

    C. T. Ritchlin;A. Kavanaugh;D. D. Gladman;P. J. Mease

  • The 'psoriatic march': a concept of how severe psoriasis may drive cardiovascular comorbidity.

    Wolf-Henning Boehncke;Sandra Boehncke;Anne-Marie Tobin;Brian Kirby

  • The IL-17 Family of Cytokines in Psoriasis: IL-17A and Beyond

    Nicolo Costantino Brembilla;Luisa Senra;Wolf-Henning Boehncke;Wolf-Henning Boehncke

  • S3 – Guidelines on the treatment of psoriasis vulgaris (English version). Update

    Alexander Nast;Wolf-Henning Boehncke;Ulrich Mrowietz;Hans-Michael Ockenfels

  • Psoriasis patients show signs of insulin resistance.

    Sandra Boehncke;Diamant Thaci;Heike Beschmann;Ralf J. Ludwig

  • Biological therapies in the systemic management of psoriasis: International Consensus Conference.

    W. Sterry;J. Barker;W.H. Boehncke;J.D. Bos

  • Guselkumab in patients with active psoriatic arthritis who were biologic-naive or had previously received TNFα inhibitor treatment (DISCOVER-1): a double-blind, randomised, placebo-controlled phase 3 trial

    Atul Deodhar;Philip S Helliwell;Wolf-Henning Boehncke;Alexa P Kollmeier

  • Systemic Inflammation and Cardiovascular Comorbidity in Psoriasis Patients: Causes and Consequences.

    Wolf-Henning Boehncke

  • Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statement.

    Peter Nash;Andreas Kerschbaumer;Thomas Dörner;Maxime Dougados

  • The role of IL-23 and the IL-23/TH17 immune axis in the pathogenesis and treatment of psoriasis

    G Girolomoni;R Strohal;L Puig;H Bachelez;H Bachelez

  • Endothelial P-Selectin as a Target of Heparin Action in Experimental Melanoma Lung Metastasis

    Ralf J. Ludwig;Beatrice Boehme;Maurizio Podda;Reinhard Henschler

  • IL-17A in Psoriasis and Beyond: Cardiovascular and Metabolic Implications.

    Esther von Stebut;Wolf-Henning Boehncke;Wolf-Henning Boehncke;Kamran Ghoreschi;Tommaso Gori

  • Efficacy and safety of guselkumab in patients with active psoriatic arthritis: a randomised, double-blind, placebo-controlled, phase 2 study.

    Atul Deodhar;Alice B Gottlieb;Wolf-Henning Boehncke;Wolf-Henning Boehncke;Bin Dong

  • Etiology and Pathogenesis of Psoriasis.

    Wolf-Henning Boehncke

  • Managing comorbid disease in patients with psoriasis

    Wolf-Henning Boehncke;Sandra Boehncke;Michael P Schön

  • Excess beta 2 microglobulin promoting functional peptide association with purified soluble class I MHC molecules.

    Steven Kozlowski;Toshiyuki Takeshita;Wolf-Henning Boehncke;Hidemi Takahashi;Hidemi Takahashi

  • Effective continuous systemic therapy of severe plaque-type psoriasis is accompanied by amelioration of biomarkers of cardiovascular risk: results of a prospective longitudinal observational study.

    Sandra Boehncke;Rebekka Salgo;Jurate Garbaraviciene;Heike Beschmann

  • Group for Research and Assessment of Psoriasis and Psoriatic Arthritis/Outcome Measures in Rheumatology Consensus-Based Recommendations and Research Agenda for Use of Composite Measures and Treatment Targets in Psoriatic Arthritis.

    Laura C Coates;Oliver Fitzgerald;Joseph F Merola;Josef Smolen

Frequent Co-Authors

Ulrich Mrowietz
Ulrich Mrowietz Kiel University
Matthias Augustin
Matthias Augustin Universität Hamburg
Ralf Ludwig
Ralf Ludwig University of Rostock
Alice B. Gottlieb
Alice B. Gottlieb Icahn School of Medicine at Mount Sinai
Philip S. Helliwell
Philip S. Helliwell University of Leeds
Dafna D. Gladman
Dafna D. Gladman Toronto Western Hospital
Christopher T. Ritchlin
Christopher T. Ritchlin University of Rochester Medical Center
Kristian Reich
Kristian Reich University of Göttingen
Philip J. Mease
Philip J. Mease University of Washington
Michael P. Schön
Michael P. Schön University of Göttingen

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Biology and Biochemistry opens many doors to healthcare and research-oriented careers. As the demand for healthcare professionals grows, many students are exploring flexible education pathways. For example, students interested in medical imaging may pursue online rad tech programs to build skills in radiology technology while balancing work and study.

Nutrition is a fast-growing field related to biochemistry, and the best dietetics masters programs offer advanced training for those aiming for a career as a registered dietitian. Another in-demand option is becoming a medical assistant, with many choosing an online medical assisting school that provides convenient, accredited healthcare training and may include financial aid opportunities.

Those already certified as medical assistants can advance their careers through a cma to lpn bridge program online, gaining new skills and entering higher-paying nursing roles. These online degree pathways make it easier to transition into specialized healthcare professions, building on a foundation in Biology and Biochemistry.

Best Scientists Citing Wolf-Henning Boehncke

Trending Scientists